期刊
JOURNAL OF PSYCHOPHARMACOLOGY
卷 26, 期 1, 页码 144-149出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881111414090
关键词
[C-11]-raclopride; addiction; cannabis; D-2/D-3 receptor; dopamine; nicotine; PET; psychosis
资金
- Medical Research Council, UK [U.1200.04.007.00001.01]
- MRC [G1002226, G0700995, G0400575] Funding Source: UKRI
- Medical Research Council [1116129, G0400575, G1002226, G0700995, MC_U120097115] Funding Source: researchfish
Cannabis use in adolescence is emerging as a risk factor for the development of psychosis. In animal studies, Delta 9-tetrahydrocannabinol (THC), the psychoactive component of cannabis, modulates striatal dopaminergic neurotransmission. Alterations in human striatal dopaminergic function have also been reported both in psychosis and in stimulant use. We sought to examine whether striatal dopamine D-2/D-3 receptor availability was altered in volunteers with a history of cannabis use using a database of previously acquired [C-11]-raclopride positron emission tomography (PET) scans. Ten [C-11]-raclopride scans from volunteers with a history of cannabis use were compared to ten control scans using a functional striatal subdivision region of interest (ROI) analysis. No significant differences in either overall striatal BPND values or BPND values in any functional striatal subdivision were found between the two groups. There was also no correlation between lifetime frequency of cannabis use and BPND values. Limbic striatal BPND values were ten percent lower in current nicotine cigarette smokers. These findings suggest that, unlike other drugs of abuse, a history of cannabis use is not associated with alterations in striatal dopamine D-2/D-3 receptor availability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据